Trials
Every trials we track across medical research, 3 entries in all, each with what it tests, design & endpoints and who is enrolled.
FDA launches pilot to accelerate phase 1 trials
The FDA has opened a pilot program pairing drug sponsors with qualified research institutions to expedite IND reviews.
Novo Nordisk ends two more phase 3 trials
Novo Nordisk has discontinued two late-stage heart failure trials for its drug ziltivekimab after a data review.
Novartis, Bristol Myers pause autoimmune CAR-T trials
Novartis and Bristol Myers Squibb have paused multiple trials of their CAR-T therapies for autoimmune diseases following serious safety incidents.
Novartis, BMS Pause CAR-T Autoimmune Trials
Novartis and Bristol Myers Squibb have paused clinical trials of their CAR T-cell therapies for autoimmune diseases following severe adverse events.
Novartis, BMS halt autoimmune CAR-T trials
Novartis paused CD19 CAR-T trials after three patient deaths, and Bristol Myers Squibb halted enrollment in a similar program due to inflammatory...
Heart Failure Drug Combo Effects Modeled
A pooled analysis of 38,753 patients from nine trials provides individualized estimates for how combinations of modern heart failure drugs affect...
AusperBio raises $120M for hepatitis B trial
AusperBio Therapeutics raised $120 million in a series C round led by RA Capital to advance its hepatitis B drug candidate AHB-137 into phase 3...
Capricor’s Duchenne Drug Study Highlights the Challenges of Rare Disease Trials
The FDA's recent decision on Capricor’s deramiocel for Duchenne muscular dystrophy underscores the complexities of rare disease clinical trials...
Experts Question Huidagene's Disclosures Following Patient Death
A recent patient death has raised concerns about Huidagene's transparency in clinical trials.